Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Current Leases (2020 - 2025)

Historic Current Leases for Lexaria Bioscience (LEXX) over the last 6 years, with Q4 2025 value amounting to $31101.0.

  • Lexaria Bioscience's Current Leases rose 794.46% to $31101.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $31101.0, marking a year-over-year increase of 794.46%. This contributed to the annual value of $30417.0 for FY2025, which is 845.01% up from last year.
  • Latest data reveals that Lexaria Bioscience reported Current Leases of $31101.0 as of Q4 2025, which was up 794.46% from $30417.0 recorded in Q3 2025.
  • Lexaria Bioscience's 5-year Current Leases high stood at $42587.0 for Q3 2022, and its period low was $25554.0 during Q4 2023.
  • For the 5-year period, Lexaria Bioscience's Current Leases averaged around $32977.8, with its median value being $30417.0 (2025).
  • As far as peak fluctuations go, Lexaria Bioscience's Current Leases tumbled by 3551.69% in 2023, and later soared by 1274.95% in 2024.
  • Over the past 5 years, Lexaria Bioscience's Current Leases (Quarter) stood at $39404.0 in 2021, then rose by 0.57% to $39629.0 in 2022, then plummeted by 35.52% to $25554.0 in 2023, then increased by 12.75% to $28812.0 in 2024, then rose by 7.94% to $31101.0 in 2025.
  • Its Current Leases was $31101.0 in Q4 2025, compared to $30417.0 in Q3 2025 and $29872.0 in Q2 2025.